These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 35098994)
1. CONVINCE in the context of existing evidence on haemodiafiltration. Vernooij RWM; Bots ML; Strippoli GFM; Canaud B; Cromm K; Woodward M; Blankestijn PJ; Nephrol Dial Transplant; 2022 May; 37(6):1006-1013. PubMed ID: 35098994 [TBL] [Abstract][Full Text] [Related]
2. Benefits and harms of high-dose haemodiafiltration versus high-flux haemodialysis: the comparison of high-dose haemodiafiltration with high-flux haemodialysis (CONVINCE) trial protocol. Blankestijn PJ; Fischer KI; Barth C; Cromm K; Canaud B; Davenport A; Grobbee DE; Hegbrant J; Roes KC; Rose M; Strippoli GF; Vernooij RW; Woodward M; de Wit GA; Bots ML BMJ Open; 2020 Feb; 10(2):e033228. PubMed ID: 32029487 [TBL] [Abstract][Full Text] [Related]
3. The high-volume haemodiafiltration vs high-flux haemodialysis registry trial (H4RT): a multi-centre, unblinded, randomised, parallel-group, superiority study to compare the effectiveness and cost-effectiveness of high-volume haemodiafiltration and high-flux haemodialysis in people with kidney failure on maintenance dialysis using linkage to routine healthcare databases for outcomes. Caskey FJ; Procter S; MacNeill SJ; Wade J; Taylor J; Rooshenas L; Liu Y; Annaw A; Alloway K; Davenport A; Power A; Farrington K; Mitra S; Wheeler DC; Law K; Lewis-White H; Ben-Shlomo Y; Hollingworth W; Donovan J; Lane JA Trials; 2022 Jun; 23(1):532. PubMed ID: 35761367 [TBL] [Abstract][Full Text] [Related]
4. Haemodiafiltration and mortality in end-stage kidney disease patients: a pooled individual participant data analysis from four randomized controlled trials. Peters SA; Bots ML; Canaud B; Davenport A; Grooteman MP; Kircelli F; Locatelli F; Maduell F; Morena M; Nubé MJ; Ok E; Torres F; Woodward M; Blankestijn PJ; Nephrol Dial Transplant; 2016 Jun; 31(6):978-84. PubMed ID: 26492924 [TBL] [Abstract][Full Text] [Related]
5. Effect of haemodiafiltration vs conventional haemodialysis on growth and cardiovascular outcomes in children - the HDF, heart and height (3H) study. Shroff R; Bayazit A; Stefanidis CJ; Askiti V; Azukaitis K; Canpolat N; Agbas A; Anarat A; Aoun B; Bakkaloglu S; Bhowruth D; Borzych-Dużałka D; Bulut IK; Büscher R; Dempster C; Duzova A; Habbig S; Hayes W; Hegde S; Krid S; Licht C; Litwin M; Mayes M; Mir S; Nemec R; Obrycki L; Paglialonga F; Picca S; Ranchin B; Samaille C; Shenoy M; Sinha M; Smith C; Spasojevic B; Vidal E; Vondrák K; Yilmaz A; Zaloszyc A; Fischbach M; Schaefer F; Schmitt CP BMC Nephrol; 2018 Aug; 19(1):199. PubMed ID: 30097064 [TBL] [Abstract][Full Text] [Related]
7. High-efficiency on-line haemodiafiltration improves conduit artery endothelial function compared with high-flux haemodialysis in end-stage renal disease patients. Bellien J; Fréguin-Bouilland C; Joannidès R; Hanoy M; Rémy-Jouet I; Monteil C; Iacob M; Martin L; Renet S; Vendeville C; Godin M; Thuillez C; Le Roy F Nephrol Dial Transplant; 2014 Feb; 29(2):414-22. PubMed ID: 24235073 [TBL] [Abstract][Full Text] [Related]
8. Haemodiafiltration does not lower protein-bound uraemic toxin levels compared with haemodialysis in a paediatric population. Snauwaert E; Van Biesen W; Raes A; Glorieux G; Vande Walle J; Roels S; Vanholder R; Askiti V; Azukaitis K; Bayazit A; Canpolat N; Fischbach M; Saoussen K; Litwin M; Obrycki L; Paglialonga F; Ranchin B; Samaille C; Schaefer F; Schmitt CP; Spasojevic B; Stefanidis CJ; Shroff R; Eloot S Nephrol Dial Transplant; 2020 Apr; 35(4):648-656. PubMed ID: 31361315 [TBL] [Abstract][Full Text] [Related]
9. The probability of receiving a kidney transplantation in end-stage kidney disease patients who are treated with haemodiafiltration or haemodialysis: a pooled individual participant data from four randomised controlled trials. Vernooij RWM; Law W; Peters SAE; Canaud B; Davenport A; Grooteman MPC; Kircelli F; Locatelli F; Maduell F; Morena M; Nubé MJ; Ok E; Torres F; Woodward M; Blankestijn PJ; Bots ML; BMC Nephrol; 2021 Feb; 22(1):70. PubMed ID: 33632160 [TBL] [Abstract][Full Text] [Related]
10. The effect of high-volume online haemodiafiltration on nutritional status and body composition: the ProtEin Stores prEservaTion (PESET) study. Molina P; Vizcaíno B; Molina MD; Beltrán S; González-Moya M; Mora A; Castro-Alonso C; Kanter J; Ávila AI; Górriz JL; Estañ N; Pallardó LM; Fouque D; Carrero JJ Nephrol Dial Transplant; 2018 Jul; 33(7):1223-1235. PubMed ID: 29370428 [TBL] [Abstract][Full Text] [Related]
11. Relative importance of residual renal function and convection in determining beta-2-microglobulin levels in high-flux haemodialysis and on-line haemodiafiltration. Fry AC; Singh DK; Chandna SM; Farrington K Blood Purif; 2007; 25(3):295-302. PubMed ID: 17622712 [TBL] [Abstract][Full Text] [Related]
13. Haemodiafiltration at Higher Volumes and Patient Survival. Locatelli F; Del Vecchio L; La Milia V Contrib Nephrol; 2017; 189():1-8. PubMed ID: 27951544 [TBL] [Abstract][Full Text] [Related]
14. A Randomized, Single-Blind, Crossover Trial of Recovery Time in High-Flux Hemodialysis and Hemodiafiltration. Smith JR; Zimmer N; Bell E; Francq BG; McConnachie A; Mactier R Am J Kidney Dis; 2017 Jun; 69(6):762-770. PubMed ID: 28024931 [TBL] [Abstract][Full Text] [Related]
15. Current Evidence in Haemodiafiltration. Locatelli F; Violo L; Longhi S; Del Vecchio L Blood Purif; 2015; 40 Suppl 1():24-9. PubMed ID: 26344510 [TBL] [Abstract][Full Text] [Related]